These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 26633466)

  • 1. Potential for Improving Potency and Specificity of Reovirus Oncolysis with Next-Generation Reovirus Variants.
    Mohamed A; Johnston RN; Shmulevitz M
    Viruses; 2015 Dec; 7(12):6251-78. PubMed ID: 26633466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring host factors that impact reovirus replication, dissemination, and reovirus-induced cell death in cancer versus normal cells in culture.
    Shmulevitz M; Lee PW
    Methods Mol Biol; 2012; 797():163-76. PubMed ID: 21948476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncolytic Viral Therapy Using Reovirus.
    Thirukkumaran C; Morris DG
    Methods Mol Biol; 2015; 1317():187-223. PubMed ID: 26072409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced Killing of Triple-Negative Breast Cancer Cells by Reassortant Reovirus and Topoisomerase Inhibitors.
    Rodríguez Stewart RM; Berry JTL; Berger AK; Yoon SB; Hirsch AL; Guberman JA; Patel NB; Tharp GK; Bosinger SE; Mainou BA
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31511390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Pyruvate Dehydrogenase Kinase Enhances the Antitumor Efficacy of Oncolytic Reovirus.
    Kennedy BE; Murphy JP; Clements DR; Konda P; Holay N; Kim Y; Pathak GP; Giacomantonio MA; Hiani YE; Gujar S
    Cancer Res; 2019 Aug; 79(15):3824-3836. PubMed ID: 31088833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncolytic viral therapy using reovirus.
    Thirukkumaran C; Morris DG
    Methods Mol Biol; 2009; 542():607-34. PubMed ID: 19565924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ras transformation mediates reovirus oncolysis by enhancing virus uncoating, particle infectivity, and apoptosis-dependent release.
    Marcato P; Shmulevitz M; Pan D; Stoltz D; Lee PW
    Mol Ther; 2007 Aug; 15(8):1522-30. PubMed ID: 17457318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reovirus and tumor oncolysis.
    Kim M; Chung YH; Johnston RN
    J Microbiol; 2007 Jun; 45(3):187-92. PubMed ID: 17618222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in the Most Oncolytic Reovirus Strain Confer Enhanced Cell Attachment, Transcription, and Single-Step Replication Kinetics.
    Mohamed A; Smiley JR; Shmulevitz M
    J Virol; 2020 Jan; 94(4):. PubMed ID: 31776267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naturally occurring reoviruses for human cancer therapy.
    Kim M
    BMB Rep; 2015 Aug; 48(8):454-60. PubMed ID: 26058397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single Amino Acid Differences between Closely Related Reovirus T3D Lab Strains Alter Oncolytic Potency
    Mohamed A; Clements DR; Gujar SA; Lee PW; Smiley JR; Shmulevitz M
    J Virol; 2020 Jan; 94(4):. PubMed ID: 31748391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses.
    Rajani K; Parrish C; Kottke T; Thompson J; Zaidi S; Ilett L; Shim KG; Diaz RM; Pandha H; Harrington K; Coffey M; Melcher A; Vile R
    Mol Ther; 2016 Feb; 24(1):166-74. PubMed ID: 26310630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of Genetically RGD σ1-Modified Oncolytic Reovirus That Enhances JAM-A-Independent Infection of Tumor Cells.
    Kawagishi T; Kanai Y; Nouda R; Fukui I; Nurdin JA; Matsuura Y; Kobayashi T
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32907973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Going (Reo)Viral: Factors Promoting Successful Reoviral Oncolytic Infection.
    Bourhill T; Mori Y; Rancourt DE; Shmulevitz M; Johnston RN
    Viruses; 2018 Aug; 10(8):. PubMed ID: 30103501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncolytic Reovirus Infection Is Facilitated by the Autophagic Machinery.
    Kemp V; Dautzenberg IJC; Limpens RW; van den Wollenberg DJM; Hoeben RC
    Viruses; 2017 Sep; 9(10):. PubMed ID: 28934149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cells loaded with oncolytic reovirus enhances antitumor activity in mice models of colorectal cancer.
    Babaei A; Soleimanjahi H; Soleimani M; Arefian E
    Biochem Pharmacol; 2021 Aug; 190():114644. PubMed ID: 34090878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PUMA and NF-kB Are Cell Signaling Predictors of Reovirus Oncolysis of Breast Cancer.
    Thirukkumaran C; Shi ZQ; Thirukkumaran P; Luider J; Kopciuk K; Spurrell J; Elzinga K; Morris D
    PLoS One; 2017; 12(1):e0168233. PubMed ID: 28099441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncolytic reovirus induces intracellular redistribution of Ras to promote apoptosis and progeny virus release.
    Garant KA; Shmulevitz M; Pan L; Daigle RM; Ahn DG; Gujar SA; Lee PW
    Oncogene; 2016 Feb; 35(6):771-82. PubMed ID: 25961930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncolytic reovirus effectively targets breast cancer stem cells.
    Marcato P; Dean CA; Giacomantonio CA; Lee PW
    Mol Ther; 2009 Jun; 17(6):972-9. PubMed ID: 19293772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trials with oncolytic reovirus: moving beyond phase I into combinations with standard therapeutics.
    Harrington KJ; Vile RG; Melcher A; Chester J; Pandha HS
    Cytokine Growth Factor Rev; 2010; 21(2-3):91-8. PubMed ID: 20223697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.